Cronos (CRON) Non-Current Deferred Tax Liability (2016 - 2026)
Cronos (CRON) recorded quarterly Non-Current Deferred Tax Liability of $4.0 million in Q1 2026, down 2.57% quarter-over-quarter from $4.1 million in Q4 2025, and down 12.69% on a YoY basis from $4.6 million in Q1 2025.
Cronos (CRON) Non-Current Deferred Tax Liability (2016 - 2026) Analysis & Trends
Cronos' Non-Current Deferred Tax Liability history runs 10 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 12.69% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (down 12.69% YoY), while the FY2025 annual figure was $4.1 million, up 14.73% from the prior year.
- Non-Current Deferred Tax Liability was $4.0 million for Q1 2026 at Cronos, down from $4.1 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $11.1 million in Q3 2024 to a low of $46000.0 in Q2 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $3.1 million across 5 years, with a median of $3.4 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Non-Current Deferred Tax Liability surged 1869.06% in 2024, then sank 69.22% in 2025.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $1.9 million in 2022, then plunged by 90.56% to $181000.0 in 2023, then soared by 1869.06% to $3.6 million in 2024, then climbed by 14.73% to $4.1 million in 2025, then retreated by 2.57% to $4.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $4.0 million (Q1 2026), $4.1 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Cronos | 1.06 Bn | 292.44 Mn | 19.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.98 Mn |
| Mar 31, 2026 | 3.98 Mn |
| Dec 31, 2025 | 4.09 Mn |
| Dec 31, 2025 | 4.09 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Sep 30, 2025 | 3.43 Mn |
| Jun 30, 2025 | 5.54 Mn |
| Jun 30, 2025 | 5.54 Mn |
| Mar 31, 2025 | 4.56 Mn |
| Mar 31, 2025 | 4.56 Mn |
| Dec 31, 2024 | 3.56 Mn |
| Dec 31, 2024 | 3.56 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Sep 30, 2024 | 11.14 Mn |
| Dec 31, 2023 | 181,000.00 |
| Dec 31, 2023 | 181,000.00 |
| Jun 30, 2023 | 675,000.00 |
| Jun 30, 2023 | 675,000.00 |
| Mar 31, 2023 | 378,000.00 |
| Mar 31, 2023 | 378,000.00 |